PMID
Cmpds
Data
Article Title
Organization
27
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.

National Institute of Diabetes and Digestive and Kidney Diseases
30
Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.

The University of Texas At Austin
13
Novel sigma 1-antagonists with cis-(+)-normetazocine scaffold: synthesis, molecular modeling, and antinociceptive effect.

University of Catania
19
Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets.

University of South Carolina
5
Neuromodulating Alkaloids from Millipede Defensive Secretions.

Virginia Tech
1
Development of Squaramides as Allosteric Modulators of the CB1 Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats.

Research Triangle Institute
36
Synthesis and structure-affinity relationships of spirocyclic σ1 receptor ligands with tetrahydropyran scaffold.

Universit£t M£nster
9
Enantiomerically Pure Indazole Bioisosteres of Ifenprodil and Ro 25-6981 as Negative Allosteric Modulators of NMDA Receptors with the GluN2B Subunit.

Universitat Munster
17
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds.

University of Catania
47
Design, synthesis and biological evaluation of arylpropylamine derivatives as potential multi-target antidepressants.

Nanjing Tech University
21
Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds.

Adam Mickiewicz University
11
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

UNC Eshelman School of Pharmacy
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.

Johann Wolfgang Goethe University
42
Structure-affinity relationships of stereoisomers of norbenzomorphan-derived σ2R/TMEM97 modulators.

The University of Texas at Austin
4
2-(Piperidin-3-yl)phthalimides reduce classical markers of cellular inflammation in LPS-challenged RAW 264.7 cells and also demonstrate potentially relevant sigma and serotonin receptor affinity in membrane preparations.

National Institute on Aging
25
Synthesis of α3β4 Nicotinic Acetylcholine Receptor Modulators Derived from Aristoquinoline That Reduce Reinstatement of Cocaine-Seeking Behavior.

University of Illinois Chicago
29
WLB-87848, a Selective σ1 Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity.

Welab Barcelona
2
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A

National Institute of Diabetes and Digestive and Kidney Disease
28
Conformationally Restricted σ

Westf£Lische Wilhelms-Universit£T M£Nster
26
Indazole as a Phenol Bioisostere: Structure-Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists.

University Munster
9
Dual

Ghent University
23
Dual Piperidine-Based Histamine H

Jagiellonian University Medical College
20
2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance.

Xuzhou Medical University
32
Targeting σ

The University of Texas At Austin
8
2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design.

Shanghaitech University
22
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y

National Institute of Diabetes and Digestive and Kidney Diseases
10
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents.

University of Pavia
14
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity.

University of Messina
28
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity.

Universit£
12
What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.

University of Illinois At Chicago
24
Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder.

High Point University
34
Discovery of WLB-89462, a New Drug-like and Highly Selective σ

Welab Barcelona
40
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.

University of Michigan
45
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.

University of Catania
19
Development of Fluorescent 4-[4-(3

University of Bari Aldo Moro
66
From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of σ1 modulators.

University of Nebraska Medical Center
38
Structure-activity relationships of mixed σ

University of Catania
25
Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y

National Institute of Diabetes and Digestive and Kidney Diseases
1
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis.

University of Kansas
24
Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.

Research Triangle Institute
18
Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities.

University of Texas At Austin
8
Synthesis of tropane-based σ

Westf£Lische Wilhelms-Universit£T M£Nster
20
Synthesis of 8-aminomorphans with high KOR affinity.

Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
2
The Alkaloids from

University of Copenhagen
103
Discovery of Highly Potent Serotonin 5-HT

Northwestern University
19
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.

University of Catania
33
Synthesis and biological evaluation of conformationally restricted GluN2B ligands derived from eliprodil.

Westf£Lische Wilhelms-Universit£T M£Nster
28
Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease.

Yeditepe University
14
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands.

University of Trieste
8
Research progress in biological activities of isochroman derivatives.

Shaanxi University of Chinese Medicine
48
Benzylaminofentanyl derivates: Discovery of bifunctional μ opioid and σ

Jiangsu Ocean University
102
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.

Beijing Normal University
15
Development of tumor-targeting aza-vesamicol derivatives with high affinity for sigma receptors for cancer theranostics.

Kanazawa University
13
Structure-Activity Studies of 1

National Institute of Diabetes and Digestive and Kidney Diseases
38
Tricyclic Triazoles as σ

Esteve Pharmaceuticals
11
Spirocyclic Scaffolds in Medicinal Chemistry.

Goethe University
18
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ

University of Bari Aldo Moro
45
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y

National Institute of Diabetes and Digestive and Kidney Diseases
8
Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic Stability.

The University of Kansas
18
Selective A

National Institute of Diabetes and Digestive and Kidney Diseases
8
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease.

Cognition Therapeutics
27
New tetrahydroisoquinoline-based D

City University of New York
15
Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ

Westf£Lische Wilhelms-Universit£T M£Nster
36
Structure-Activity Relationship of Heterocyclic P2Y

National Institute of Diabetes and Digestive and Kidney Diseases
35
Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management.

The State University of New Jersey
19
Novel σ

Westf£Lische Wilhelms-Universit£T M£Nster
16
Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σ

Guangdong Medical University
25
Studies on the affinity of 6-[(

Helmholtz-Zentrum Dresden-Rossendor
30
Synthesis and SAR Studies of 1

University of Nebraska Medical Center
29
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.

Soochow University
4
Ifenprodil Stereoisomers: Synthesis, Absolute Configuration, and Correlation with Biological Activity.

Westf£Lische Wilhelms-Universit£T M£Nster
42
Isoquinolinone derivatives as potent CNS multi-receptor D

Jiangsu Ocean University
5
The Essential Medicinal Chemistry of Cannabidiol (CBD).

University of Minnesota
17
Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds.

Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
10
Sigma-1 and Sigma-2 Receptor Modulators as Potential Therapeutics for Alzheimer's Disease.

Usona Institute
11
Fluorinated 2-Arylcyclopropan-1-amines - A new class of sigma receptor ligands.

Universit£T M£Nster
8
Synthesis and

Wilhelms-Universit�T M�Nster Corrensstr
13
Virtual Screening for Ligand Discovery at the σ

Harvard Medical School
20
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents.

University of Modena and Reggio Emilia
20
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation.

University of Catania
17
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands.

University of Trieste
1
Isolation and Synthesis of Veranamine, an Antidepressant Lead from the Marine Sponge

University of Mississippi
28
Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines.

Westf£Lische Wilhelms-Universit£T M£Nster
12
Benzimidazolone-based selective σ

University of Florida
15
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists.

National Institute of Diabetes and Digestive and Kidney Diseases
50
Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy.

East China Normal University
4
Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (σ

Memorial Sloan Kettering Cancer Center
112
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D

National Institute of Neurological Disorders and Stroke
27
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A

Medical College of Wisconsin
20
Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ

Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
13
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.

University of Catania
32
Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands.

Northwestern University
23
SYA 013 analogs as moderately selective sigma-2 (σ

Florida A&M University
34
Synthesis and Structure-Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety.

Universit£T M£Nster
21
Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation.

Universit£T M£Nster
37
Design and in Vivo Characterization of A

Medical College of Wisconsin
12
Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.

Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
10
Impact of hydroxy moieties at the benzo[7]annulene ring system of GluN2B ligands: Design, synthesis and biological evaluation.

Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
25
3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HT

University of Minnesota Twin Cities
17
Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.

University of Trieste
6
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

Qbi Covid-19 Research Group (Qcrg)
9
Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.

Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
37
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.

IQM-CSIC
27
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.

University of Pavia
15
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation.

University of Trieste
10
Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.

Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
9
Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ

University of Bari Aldo Moro
33
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.

Csir-National Chemical Laboratory
5
Synthesis of 3-aza[4.4.3]propellanes with high σ

Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
11
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.

Mazandaran University of Medical Sciences
25
Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.

Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
44
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y

National Institute of Diabetes and Digestive and Kidney Diseases
9
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.

Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
42
Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety.

Universit£T M£Nster
24
Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.

University of Texas At Austin
25
Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.

Guangdong Medical University
6
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.

Iqog, Csic
37
Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands.

Universities of Lille
46
Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novelσ

Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
6
Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter?

Helmholtz-Zentrum Dresden-Rossendorf
25
Return of D

University of Nebraska Medical Center
7
Synthesis of conformationally restricted 1,3-dioxanes to analyze the bioactive conformation of 1,3-dioxane-basedσ

Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
17
Lipase-catalyzed kinetic resolution as key step in the synthesis of enantiomerically pureσ ligands with 2-benzopyran structure.

Universit£T M£Nster
9
Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect.

University of Catania
7
Reevaluation of fenpropimorph as aσ receptor ligand: Structure-affinity relationship studies at humanσ

Virginia Commonwealth University
128
SPIROCYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION

Genentech
60
A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF

Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)
51
PLASMA KALLIKREIN INHIBITORS

Merck Sharp & Dohme
413
Acylsulfamide Compound and Pharmaceutical Use Therefor

Japan Tobacco
31
N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF

Shenzhen Edk Pharmaceutical Technology
96
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Incyte
1026
Substituted pyrazolo[1,5-a]pyrimidines as TYK2 inhibitors

Nimbus Lakshmi
119
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof

Allergan
329
Arylquinazolines

Merck Patent
6
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

Pfizer
15
Selective NR2B antagonists

Bristol Myers Squibb
72
Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

Merck Sharp & Dohme
32
Benzothiazole compounds and uses thereof

Incyte
70
Use of physiological cooling active ingredients, and agents containing such active ingredients

Symrise
24
Selective histone deactylase 6 inhibitors

H. Lee Moffitt Cancer Center and Research Institute
2
Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics

Galderma Research & Development
3
Optimization of a direct spectrophotometric method to investigate the kinetics and inhibition of sialidases.

Universit�� Degli Studi Di Siena
47
Highly Potent Cell-Permeable and Impermeable NanoLuc Luciferase Inhibitors.

Promega Biosciences
195
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases

Merck Sharp & Dohme
100
Inhibition of WDR5 interaction with its binding partners

University of Michigan
90
N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer

Korea Research Institute of Chemical Technology